Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
We’ve got all the latest on the huge news that broke late yesterday: CBER chief George Tidmarsh has resigned from the FDA, following a investigation prompted by allegations from a former collaborator and infighting at the agency.
Also, Pfizer has sued Novo Nordisk after the latter tried to block its acquisition of obesity biotech Metsera.
Continue to STAT+ to read the full story…
STAT Pharma: The science and business of new drug development
Leave a Reply